Alnylam Pharmaceuticals, Inc. (ALNY)
248.68
+1.17
(+0.47%)
USD |
NASDAQ |
Sep 11, 16:00
248.73
+0.05
(+0.02%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Return Level : 248.68 for Sept. 11, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 11, 2026 | 248.68 |
| September 10, 2026 | 247.51 |
| September 09, 2026 | 258.00 |
| September 08, 2026 | 260.10 |
| September 04, 2026 | 266.11 |
| September 03, 2026 | 264.50 |
| September 02, 2026 | 267.40 |
| September 01, 2026 | 246.11 |
| August 31, 2026 | 240.69 |
| August 28, 2026 | 237.10 |
| August 27, 2026 | 236.56 |
| August 26, 2026 | 239.00 |
| August 25, 2026 | 240.08 |
| August 24, 2026 | 236.01 |
| August 21, 2026 | 236.22 |
| August 20, 2026 | 229.30 |
| August 19, 2026 | 242.61 |
| August 18, 2026 | 228.61 |
| August 17, 2026 | 224.60 |
| August 14, 2026 | 228.65 |
| August 13, 2026 | 227.12 |
| August 12, 2026 | 223.95 |
| August 11, 2026 | 221.20 |
| August 10, 2026 | 216.98 |
| August 07, 2026 | 219.20 |
| Date | Value |
|---|---|
| August 06, 2026 | 216.12 |
| August 05, 2026 | 228.72 |
| August 04, 2026 | 219.00 |
| August 03, 2026 | 220.33 |
| July 31, 2026 | 205.52 |
| July 30, 2026 | 205.48 |
| July 29, 2026 | 286.62 |
| July 28, 2026 | 288.41 |
| July 27, 2026 | 278.40 |
| July 24, 2026 | 271.77 |
| July 23, 2026 | 268.74 |
| July 22, 2026 | 266.99 |
| July 21, 2026 | 271.37 |
| July 20, 2026 | 272.67 |
| July 17, 2026 | 267.47 |
| July 16, 2026 | 283.15 |
| July 15, 2026 | 279.14 |
| July 14, 2026 | 281.26 |
| July 13, 2026 | 288.06 |
| July 10, 2026 | 298.76 |
| July 09, 2026 | 312.79 |
| July 08, 2026 | 323.50 |
| July 07, 2026 | 321.59 |
| July 06, 2026 | 313.04 |
| July 02, 2026 | 312.78 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Ionis Pharmaceuticals, Inc. | 54.21 |
| BridgeBio Pharma, Inc. | 72.44 |
| Regeneron Pharmaceuticals, Inc. | 788.74 |
| Vertex Pharmaceuticals, Inc. | 515.44 |
| Pfizer Inc. | 92.72 |